Voloridge Investment Management
PTLA

Voloridge Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Voloridge Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-118,955
Closed -$848K – 1608
2020
Q1 		$848K Buy
+118,955
New +$1.48M 0.02% 556
2017
Q3 		– Sell
-113,659
Closed -$6.38M – 580
2017
Q2 		$6.38M Buy
+113,659
New +$4.55M 0.16% 147

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Voloridge Investment Management's PTLA Position: Q2 2020 in Review

Voloridge Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 118,955 shares — an estimated $848K sold.

Voloridge Investment Management first reported a position in PTLA in Q2 2017 and held it in 2 quarters. The position peaked at $6.38M in Q2 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Voloridge Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 118,955 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $848K.
  • Voloridge Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 2 quarters.
  • Voloridge Investment Management's Portola Pharmaceuticals, Inc. position peaked at $6.38M in Q2 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Voloridge Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.